{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:58:30Z","timestamp":1790110710194,"version":"4.0.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"intramural funds of the National Institute on Drug Abuse"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","sleep-journal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.sleep.2018.02.002","type":"journal-article","created":{"date-parts":[[2018,2,24]],"date-time":"2018-02-24T03:18:47Z","timestamp":1519442327000},"page":"94-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Treatment of restless legs syndrome\/Willis-Ekbom disease with the non-selective ENT1\/ENT2 inhibitor dipyridamole: testing the adenosine hypothesis"],"prefix":"10.1016","volume":"45","author":[{"given":"Diego","family":"Garcia-Borreguero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Guitart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Garcia Malo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Cano-Pumarega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"Granizo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Ferr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2018.02.002_bib1","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.sleep.2012.08.004","article-title":"Long-term use of pramipexole in the management of restless legs syndrome","volume":"13","author":"Lipford","year":"2012","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2018.02.002_bib2","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.sleep.2010.11.002","article-title":"A\u00a010-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome","volume":"12","author":"Silver","year":"2011","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2018.02.002_bib3","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.sleep.2015.05.028","article-title":"Natural course of restless legs syndrome\/Willis-Ekbom disease: long-term observation of a large clinical cohort","volume":"16","author":"Mitterling","year":"2015","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2018.02.002_bib4","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.sleep.2014.05.009","article-title":"Altered brain iron homeostasis and dopaminergic function in restless legs syndrome (Willis-Ekbom disease)","volume":"15","author":"Earley","year":"2014","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2018.02.002_bib5","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.expneurol.2014.06.023","article-title":"Low brain iron effects and reversibility on striatal dopamine dynamics","volume":"261","author":"Unger","year":"2014","journal-title":"Exp Neurol"},{"key":"10.1016\/j.sleep.2018.02.002_bib6","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1093\/brain\/awp125","article-title":"Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome","volume":"132","author":"Connor","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.sleep.2018.02.002_bib7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neuropharm.2016.09.002","article-title":"Adenosine receptors as markers of brain iron deficiency: implications for Restless Legs Syndrome","volume":"111","author":"Quiroz","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.sleep.2018.02.002_bib8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.sleep.2016.08.019","article-title":"In search of alternatives to dopaminergic ligands for the treatment of restless legs syndrome: iron, glutamate, and adenosine","volume":"31","author":"Ferr\u00e9","year":"2017","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2018.02.002_bib9","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ana.25104","article-title":"Targeting hypersensitive corticostriatal terminals in restless legs syndrome","volume":"82","author":"Yepes","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.sleep.2018.02.002_bib10","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.sleep.2014.03.025","article-title":"Restless legs syndrome\/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria\u2013history, rationale, description, and significance","volume":"15","author":"Allen","year":"2014","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2018.02.002_bib11","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.5665\/sleep.2820","article-title":"Validation of the multiple suggested immobilization test: a test for the assessment of severity of restless legs syndrome (Willis-Ekbom disease)","volume":"36","author":"Garcia-Borreguero","year":"2013","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2018.02.002_bib12","series-title":"For the American academy of sleep medicine. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications","author":"Iber","year":"2007"},{"key":"10.1016\/j.sleep.2018.02.002_bib13","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/brain\/awm244","article-title":"Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies","volume":"131","author":"Fulda","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.sleep.2018.02.002_bib14","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/sj.bjp.0706043","article-title":"Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists","volume":"144","author":"Schindler","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.sleep.2018.02.002_bib15","doi-asserted-by":"crossref","first-page":"948","DOI":"10.2174\/156802611795347582","article-title":"Molecular biology of nucleoside transporters and their distributions and functions in the brain","volume":"11","author":"Parkinson","year":"2011","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.sleep.2018.02.002_bib16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jchemneu.2005.12.001","article-title":"Localization of equilibrative nucleoside transporters in the rat brain","volume":"31","author":"Alanko","year":"2006","journal-title":"J\u00a0Chem Neuroanat"},{"key":"10.1016\/j.sleep.2018.02.002_bib17","doi-asserted-by":"crossref","first-page":"C808","DOI":"10.1152\/ajpcell.00243.2015","article-title":"Novel regulation of equilibrative nucleoside transporter 1 (ENT1) by receptor-stimulated Ca2+-dependent calmodulin binding","volume":"310","author":"Bicket","year":"2016","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.sleep.2018.02.002_bib18","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S0028-3908(00)00207-0","article-title":"Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system","volume":"40","author":"Jennings","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.sleep.2018.02.002_bib19","doi-asserted-by":"crossref","first-page":"s39","DOI":"10.1161\/ATVBAHA.107.160226","article-title":"Translational therapeutics of dipyridamole","volume":"28","author":"Kim","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945718300492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945718300492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T21:22:31Z","timestamp":1535059351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945718300492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":19,"alternative-id":["S1389945718300492"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2018.02.002","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of restless legs syndrome\/Willis-Ekbom disease with the non-selective ENT1\/ENT2 inhibitor dipyridamole: testing the adenosine hypothesis","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2018.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}